androsterone glucuronide has been researched along with Congenital Adrenal Hyperplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auchus, RJ; Buschur, EO; Chang, AY; Gonzalez, M; Hammer, GD; Jiao, J; Madrigal, D; Ramm, C; Smit, JW; Wang, G; Xu, XS; Yu, MK | 1 |
del Blazo, P; Ueshiba, H; Whorwood, CB | 1 |
1 trial(s) available for androsterone glucuronide and Congenital Adrenal Hyperplasia
Article | Year |
---|---|
Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Abiraterone Acetate; Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Androgens; Androstadienes; Androstenedione; Androsterone; Desoxycorticosterone; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Treatment Outcome | 2014 |
1 other study(ies) available for androsterone glucuronide and Congenital Adrenal Hyperplasia
Article | Year |
---|---|
Plasma levels of C19 steroid glucuronides in pre-menopausal women with non-classical congenital adrenal hyperplasia.
Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androstane-3,17-diol; Androsterone; Animals; Cross Reactions; Dihydrotestosterone; Female; Glucocorticoids; Heterozygote; Humans; Menopause; Rats | 1992 |